Prices · Verified July 27, 2026
What semaglutide actually costs
One molecule, four US brands, and a price range of roughly twenty to one. Here is every published figure and what decides which of them applies to you.
The short answer
Semaglutide costs between $69–$300/mo compounded and ~$1,349/mo at brand list price. The two figures most people actually meet sit in between: about $25 a month with commercial insurance that covers your brand, capped at $100 of help per month, or $149–$349 a month buying an FDA-approved product straight from the manufacturer without insurance.
Key takeaways
- There is no single price. The same molecule ranges from $69–$300/mo compounded to ~$1,349/mo at Wegovy's list price — a spread of roughly twenty times.
- Paying the manufacturer directly is the cheapest FDA-approved route: the oral products start at $149/mo (1.5 mg), and the injectable pens run $199/mo for the first 2 fills, then $349.
- With commercial insurance that covers your brand, the savings card brings the copay to about $25 — but it contributes at most $100 a month. If your plan leaves you $250, you pay $150, not $25.
- Brand decides indication, not chemistry. Ozempic and the Ozempic pill are labelled for type 2 diabetes; Wegovy and the Wegovy pill for weight management. Insurers price them differently for that reason alone.
- The dose you settle on costs more than the dose you start on. Oral semaglutide starts at from $149/mo and reaches $299/mo (9 mg and 25 mg) at maintenance strengths.
- Compounded semaglutide is the cheapest number on this page and the only one that is not an FDA-approved finished drug. That is a different kind of decision, not just a cheaper one.
- Government insurance — Medicare, Medicaid, TRICARE, VA — cannot use any manufacturer savings card. Federal anti-kickback law bars it.
Every semaglutide product and what it costs
Cash prices are what the manufacturer publishes for someone paying directly. The insured column assumes commercial insurance that covers that specific brand — without coverage the card does nothing, because there is no copay for it to reduce.
| Product | Form | Approved for | Paying cash | With covering insurance |
|---|---|---|---|---|
| Ozempic (pen) | Weekly injection | Type 2 diabetes | $199/mo for the first 2 fills, then $349 (0.25/0.5/1 mg) or $499 (2 mg) | As little as $25/mo with the savings card |
| Ozempic tablets ("the Ozempic pill") | Daily tablet | Type 2 diabetes | $149/mo (1.5 mg) · $199/mo (4 mg) · $299/mo (9 mg) | as little as $25/mo, card pays up to $100/mo |
| Wegovy (pen) | Weekly injection | Chronic weight management | $199/mo for the first 2 fills, then $349, then ~$349/mo for maintenance doses | As little as $25/mo with the savings card |
| Wegovy pill | Daily tablet | Chronic weight management | from $149/mo; $299/mo (9 mg and 25 mg) | As little as $25/mo with the savings card |
| Wegovy HD | Weekly injection, 7.2 mg | Chronic weight management | ~$399/mo | As little as $25/mo with the savings card |
| Compounded semaglutide | Vial and syringe, usually weekly | Not FDA-approved as a finished drug | $69–$300/mo | Not covered by insurance or any manufacturer card |
List price is included for reference only. Almost nobody pays it — it is the figure before insurer rebates and manufacturer programs, and it exists mainly as the baseline those discounts are quoted against.
The $25 figure, and the cap nobody prints beside it
Every savings-card page in this category leads with “as little as $25 a month”. It is true, and on its own it is misleading. The card contributes at most $100 a month toward whatever your plan leaves you, so $25 appears only when your copay is small to begin with:
- Plan leaves you $125 → card pays $100, you pay $25. This is the advertised case.
- Plan leaves you $250 → card pays $100, you pay $150.
- Deductible not yet met, plan paying nothing → the card offsets $100 of the full price and you pay the rest. This is why January and February surprise people.
Caps differ by product and are printed in each card's own terms — Trulicity, for example, stops at $150 per one-month fill and $1,950 per calendar year. Read the card you are actually handed rather than assuming a common figure.
What decides which price you pay
1.Which brand you are prescribed
Semaglutide is sold under four US brands, and the brand fixes the indication rather than the chemistry. Ozempic and the Ozempic pill are labelled for type 2 diabetes; Wegovy, the Wegovy pill and Wegovy HD for chronic weight management. Plans that exclude "weight-loss drugs" as a category can cover Ozempic and refuse Wegovy on the same day, for the same person, containing the same molecule.
2.Whether your plan covers that brand at all
This is the single biggest fork. With coverage, the savings card applies and the copay lands near $25. Without it, the card is worthless — it can only reduce a copay that exists — and you are on the manufacturer's self-pay ladder instead. Ask your insurer for the copay on your specific brand before assuming either path.
3.Which dose you are on
Manufacturer self-pay prices are per strength, not flat. Oral semaglutide runs from $149/mo at the starting strengths and $299/mo (9 mg and 25 mg) at the strengths people stay on. Budgeting a year at the escalation price understates the real figure by roughly half.
4.How the manufacturer counts a month
Novo defines a month of tablets as one bottle of 30 and a month of pens as one box. Those are not the same interval, so a "per month" tablet price and a "per month" pen price are not directly comparable. Lilly counts a Zepbound month as 28 days, which produces thirteen fills a year rather than twelve — the same arithmetic trap in a different product.
5.Whether you keep to a refill window
Some manufacturer prices are conditional on refilling inside a set number of days. Miss the window and the price steps up. That turns a discount into a calendar commitment, which is worth knowing before you plan around the lower number.
What a year costs
Annual figures use the maintenance price, not the starting one. That single choice is the most common budgeting error on this drug.
- Oral semaglutide at $299/mo (9 mg and 25 mg) → about $3,588 a year.
- Pen at ~$349/mo for maintenance doses → about $4,188 a year.
- Compounded at the low end of $69–$300/mo → about $828 a year, with the FDA caveat above.
- A savings card capped at $100 a month contributes at most $1,200 across a year, however large your copay is.
If you have Medicare or Medicaid
No manufacturer savings card can be used by anyone enrolled in a government-funded plan — Medicare including Part D and Advantage, Medicaid, TRICARE, VA, or a state pharmaceutical assistance program. That is federal anti-kickback law rather than a manufacturer policy, so it is not negotiable. Medicare Part D is also statutorily barred from covering a drug used for weight loss alone, though it may cover semaglutide prescribed for type 2 diabetes or, under the 2024 indication expansion, for established cardiovascular disease. Some patients on government plans step outside their insurance and pay the manufacturer self-pay price instead, which is permitted — but then the plan contributes nothing.
Where to get semaglutide prescribed
SponsoredTelehealth providers ranked by what a first month actually costs, consultation fee included. We earn a commission if you sign up — it does not change your price.
Advertising disclosure: we may earn a commission if you sign up through these links, at no extra cost to you — it never affects our rankings. How we make money
Common questions about this medication
How much does semaglutide cost per month?
It depends on the brand and the route, and the spread is very wide. Compounded semaglutide runs $69–$300/mo but is not an FDA-approved finished drug. Buying an FDA-approved product from the manufacturer without insurance: the Ozempic tablets are $149/mo (1.5 mg) at the starting strength rising to $299/mo (9 mg), and the Wegovy and Ozempic pens run $199/mo for the first 2 fills, then $349. Wegovy's list price, which almost nobody pays, is ~$1,349/mo. With commercial insurance that covers your brand, the savings card typically brings the copay to about $25, subject to the cap described below.
Why does the same drug have so many different prices?
Because you are not really buying a molecule, you are buying a specific branded product through a specific channel. The brand sets the approved indication, which decides whether your plan treats it as diabetes care or as weight management. The channel — insurance with a card, manufacturer self-pay, or a compounding pharmacy — sets the list you are priced from. And within each channel the price varies by dose. Four brands times three channels times several strengths is why one molecule has more than a dozen legitimate prices at the same moment.
Is the $25 savings card price real?
It is real and it is capped, and the cap is what most pages leave out. The card pays up to $100 a month toward what your plan leaves you. So "as little as $25" describes what happens when your copay is small enough for that contribution to close the gap. If your plan leaves you a $250 copay, the card takes $100 off and you pay $150. Early in the calendar year, before a deductible is met, plans often pay nothing at all, and the card is working against the full price. Ask your plan for your actual copay figure before budgeting on $25.
Is compounded semaglutide cheaper?
Yes, materially — $69–$300/mo against $199/mo for the first 2 fills, then $349 for the brand pens. It is also a different category of product. Compounded semaglutide is not FDA-approved as a finished drug: the agency reviews the active ingredient, not the compounded preparation, so potency and sterility rest on the pharmacy rather than on a manufacturing approval. The shortage that justified large-scale compounding of semaglutide ended in early 2025, which narrowed the legal basis for routine copies. Treat the price gap as the compensation for a different risk profile, not as the same product on sale.
Does insurance cover semaglutide?
Sometimes, and the answer usually turns on indication rather than on the drug. Coverage for type 2 diabetes is common; coverage for weight management is not, and many employer plans exclude anti-obesity medication as a category. Where a plan does cover weight management it typically requires prior authorization with a documented BMI threshold — commonly 30, or 27 with a weight-related condition — and sometimes evidence of a supervised attempt first. Medicare Part D is statutorily barred from covering a drug used for weight loss alone, though it may cover semaglutide prescribed for diabetes or, since the 2024 cardiovascular indication, for established cardiovascular disease.
What is the cheapest way to get semaglutide?
By raw price, compounded semaglutide at $69–$300/mo, with the FDA caveat above. Among FDA-approved products the cheapest entry point is oral semaglutide at $149/mo (1.5 mg) for the starting strength, though that is not a dose anyone stays on. If you have commercial insurance that covers your brand, the savings card usually beats every cash route. Our ranked comparison is on the cheapest-semaglutide page, which orders the routes by what you actually pay rather than by headline price.
How much is semaglutide per year?
Multiply the maintenance figure rather than the starting one, and check how the manufacturer counts a month. On oral semaglutide at $299/mo (9 mg and 25 mg), a year is roughly $3,588. On the pens at ~$349/mo for maintenance doses, roughly $4,188. With a savings card capped at $100 a month, the card contributes at most $1,200 across the year regardless of how large your copay is. Compounded routes at the low end come to around $828 a year.
Why did my price go up after the first two months?
Because you were on an introductory rate. NovoCare's self-pay offer prices the first two fills at $199 and then moves to the standing rate — ~$349/mo for maintenance doses for the Wegovy pen, and $349 or $499 for the Ozempic pen depending on strength. The same pattern applies to oral semaglutide, where the lowest advertised figure belongs to the escalation strengths rather than the one you settle on. An introductory price is a real price; it is just not the one to plan a year around.
Related
Prices read from NovoCare, ozempic.com and Novo Nordisk's published price guides on July 27, 2026, and held in one canonical module so a change updates every page at once. Manufacturer programs change without notice — confirm the current figure before budgeting on it. Compounded pricing is the range across the telehealth providers we list. GLP1Zoom is not a pharmacy, issues no coupons, and does not prescribe. Educational only, not medical advice.